Scarica l'app Stockscreener
7.87
5.78%
0.43
Kala Bio Inc Borsa (KALA) Ultime notizie
Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade - Yahoo Finance
What’s next for KALA BIO Inc. stock priceJuly 2025 Volume & Daily Entry Point Alerts - Newser
Technical analysis overview for KALA BIO Inc. stockMarket Performance Recap & Real-Time Volume Trigger Notifications - Newser
Comparing KALA BIO Inc. in custom built stock radars2025 Risk Factors & Intraday High Probability Alerts - Newser
Statistical indicators supporting KALA BIO Inc.’s strengthNew Guidance & Safe Entry Point Alerts - Newser
KALA BIO Inc. stock trend forecastPredictive AI Signals for Short-Term Trading - Newser
Can KALA BIO Inc. recover in the next quarterWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
Is KALA BIO Inc. a Top Dividend Stock to Watch in 2025High Probability Trade Outcome Prediction - Newser
Is KALA BIO Inc. showing insider buyingROIC-Focused Investment List - thegnnews.com
Why KALA BIO Inc. stock attracts strong analyst attentionMachine Learning Stock Movement Detector - Newser
How KALA BIO Inc. stock performs during market volatilityShort-Term Market Movement Forecast Report - Newser
Using portfolio simulators with KALA BIO Inc. includedFree Swing Setup With Technical Confirmation - Newser
What makes KALA BIO Inc. stock price move sharplyFree Risk Managed Intraday Trade Alerts - Newser
Can volume confirm reversal in KALA BIO Inc.Free AI Screening for Swing Trade Picks - Newser
Kala Bio Reports Q2 2025 Earnings: EPS -$1.82, Revenue Unavailable; Focus on Advancing KPI-012 for Rare Eye Diseases. - AInvest
Trend analysis for KALA BIO Inc. this weekWeekly Trend Watch with Market Signals - Newser
What drives KALA BIO Inc.’s stock priceStocks with 300% Upside - sisaissue.com
KALA BIO: Q2 Earnings Snapshot - Greenwich Time
KALA BIO (NASDAQ:KALA) Stock Rating Lowered by Wall Street Zen - Defense World
Momentum divergence signals in KALA BIO Inc. chartShort-Term Profit Alert With Entry Forecast - Newser
Kala Bio (KALA) Q2 Loss Widens 15% - AOL.com
KALA BIO Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Kala Bio Q2 Loss Widens 15%, KPI-012 Enrollment Completed - AInvest
Biotech's Long Game: Assessing KALA BIO's Q2 Loss in the Context of Strategic Innovation - AInvest
Kala Bio (KALA) Q2 Loss Widens 15% - The Motley Fool
KALA BIO, Inc. Completes Patient Enrollment in Phase 2b CHASE Trial for KPI-012 in Persistent Corneal Epithelial Defect, Reports Financial Results and Upcoming Milestones - Quiver Quantitative
KALA BIO, Inc. SEC 10-Q Report - TradingView
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
KALA BIO Reports Second Quarter 2025 Financial Results and Provi - GuruFocus
Kala Bio shares rise 3.83% premarket after announcing presentation at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference | KALA Stock News - GuruFocus
KALA BIO, Inc. to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025 - Quiver Quantitative
KALA BIO to present at H.C. Wainwright Ophthalmology Virtual Conference. - AInvest
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewswire
KALA BIO Showcases Breakthrough Eye Disease Treatments at Major Ophthalmology Conference - Stock Titan
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):